Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Masatoshi Kudo, MD, PhD, Kindai University Faculty of Medicine
home
Articles
Emerging Therapies for HCC Management
June 29th 2020
Metastatic HCC Unmet Needs
June 29th 2020
I/O Second-Line Treatment
June 29th 2020
REACH and REACH2 Trial Overview
June 29th 2020
Second-Line Therapy: Monoclonal Antibody
June 29th 2020
Second-Line Sequencing After IMbrave150 Regimen
June 29th 2020
R/R HCC: Second-Line Options
June 29th 2020
Frontline I/O: Clinical Trial Overviews
June 29th 2020
Frontline Therapy: Promising I/O Combinations
June 29th 2020
Phase 3 IMbrave150 Trial
June 29th 2020
Frontline Decision Factors for Metastatic Disease
June 29th 2020
HCC Treatment Algorithm: Asia and Europe
June 29th 2020
Transitioning From Locoregional to Systemic Therapy
June 29th 2020
HCC Diagnosis and Prognosis
June 29th 2020
The Evolving Role of Medical Oncologists and Hepatologists
June 29th 2020
HCC Global Screening Programs for At-Risk Populations
June 29th 2020
HCC Etiologic Risk Factors and Global Prevalence
June 29th 2020